COMMUNIQUÉS West-GlobeNewswire

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
10/07/2024
PRESS RELEASE REGULATED INFORMATION 10 July 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 10 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA [...]
GrayHawk Health Leverages Innovaccer’s Technology to Transform In-Home Healthcare for At Risk Populations
10/07/2024
PA-based GrayHawk Health will use Innovaccer’s Population Health Analytics and Data Platform to accelerate development of its healthcare experience platform (HXP) , validate quality and to improve in-home care delivery [...]
Elite MedSpa, Ivy En Rose, Unveils Groundbreaking Longevity Program and Announces Upcoming Launch of Membership Rewards
10/07/2024
SAN FRANCISCO, July 10, 2024 (GLOBE NEWSWIRE) -- Ivy En Rose , an elite medspa in San Francisco, is thrilled to announce the launch of their innovative Longevity Program, designed to help clients achieve and maintain [...]
FSH-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomized clinical trial
10/07/2024
AMSTERDAM, July 10, 2024 (GLOBE NEWSWIRE) -- This randomized, controlled trial was conducted at a tertiary IVF center, Ho Chi Minh City, Vietnam. Between January 2023 and June 2023, 120 women were randomized. Eligible [...]
Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage
10/07/2024
The Company believes that its Advanced Proprietary Production Technology Provides it with a Competitive Advantage in the Sector BEIJING, July 10, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; [...]
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10/07/2024
DENVER, July 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 947, [...]
Two USOSM Partner Practices Receive AAAHC Accreditation
10/07/2024
Recognition Enables Oral and Maxillofacial Surgery Centers of Excellence Distinction IRVING, Texas, July 10, 2024 (GLOBE NEWSWIRE) -- The Accreditation Association for Ambulatory Health Care ( AAAHC ) has accredited two [...]
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
10/07/2024
Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, [...]
Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction
10/07/2024
Skyhawk’s SKY-0515 demonstrated dose-dependent huntingtin (HTT) mRNA reduction in healthy volunteers, with 72% reduction at the highest dose tested in the multiple ascending dose study SKY-0515 was generally well [...]
Creative Medical Technology Holdings Provides Corporate Update
10/07/2024
PHOENIX, July 10, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ) , a biotechnology company focused on a regenerative approach to [...]
Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida
10/07/2024
Reports progress in reimbursement strategy with additional JMAC regions ROSELAND, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery [...]
Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
10/07/2024
Dr. Flomenberg and Dr. Grosso are leading experts in T cell biology and its clinical applications Tevogen’s ExacTcell™ platform is designed to address current cost, and patient accessibility challenges ExacTcell’s first [...]
Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
10/07/2024
RECCE ® 327 (R327) demonstrated significant bactericidal activity against ‘superbug’ Acinetobacter baumannii ( A. baumannii ) demonstrating 99.99999% log reduction (>7.5 log reduction) in adult human epidermal ‘skin [...]
Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
10/07/2024
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9 [...]
Tr1X Announces First Patient Dosed in Proof of Concept GvHD Trial Evaluating TRX103, a First-in-Class Type 1 Treg (Tr1) Cell Therapy
10/07/2024
TRX103 is designed to reset the immune system, improve clinical outcomes, and potentially cure patients suffering from autoimmune and inflammatory disorders This marks the first use of an allogeneic engineered Type 1 [...]
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
10/07/2024
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its [...]
Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
10/07/2024
CEO to participate in ARVO SIG panel on oral medications for retinal diseases ZETA-1 Phase 2 clinical trial subset analysis to be presented during the ASRS 42 nd Annual Scientific Meeting FARMINGTON HILLS, Mich., July [...]
Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model
10/07/2024
Certepetide shown to promote immune cell infiltration into tumors and inhibit metastasis BASKING RIDGE, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a [...]
Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB
10/07/2024
Key Opinion Leader (KOL) event with Dr. Mark Sulkowski to discuss his perspectives on the chronic suppression regulatory pathway and future development plans following positive feedback from the FDA to move forward with [...]

Pages